糖尿病性足潰瘍(DFU)治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21APR1827)
◆英語タイトル:Global Diabetic Foot Ulcer Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR1827
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年4月
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥526,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥789,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、糖尿病性足潰瘍(DFU)治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子)、用途別市場規模(病院、専門クリニック、介護センター、外来手術センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・糖尿病性足潰瘍(DFU)治療の市場動向
・企業の競争状況、市場シェア
・糖尿病性足潰瘍(DFU)治療の種類別市場規模(事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子)
・糖尿病性足潰瘍(DFU)治療の用途別市場規模(病院、専門クリニック、介護センター、外来手術センター)
・糖尿病性足潰瘍(DFU)治療の北米市場規模2016-2027(アメリカ、カナダ)
・糖尿病性足潰瘍(DFU)治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・糖尿病性足潰瘍(DFU)治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・糖尿病性足潰瘍(DFU)治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・糖尿病性足潰瘍(DFU)治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(B.Braun Melsungen、Smith & Nephew、Organogenesis、Derma Sciences、Sigvaris、3M、Acelity、Innocoll Holdings、SIGVARIS、Osiris)
・結論
【レポートの概要】

Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing breakthrough advanced wound dressings for diabetic foot ulcer management. This includes novel dressings with the ability to confer moisture balance with prolonged time of action, extended oxygen permeability, antimicrobial activity, growth factor stimulation, and the ability to promote autolytic debridement thus facilitating the re-epithelialization process. This factor is creating robust development in the global diabetic foot ulcer therapeutics market.
A growing population affected by diabetes and a subsequent increase in the number of people afflicted with diabetic foot ulcer is likely to impact the global diabetic foot ulcer therapeutics market in a positive manner over the forecast period. Furthermore, continued prioritization to avoid surgeries and amputations is expected to fuel the growth of the global diabetic foot ulcer therapeutics market over the predicted period. Diabetes mellitus is one of the most important public health concerns worldwide, with an increased risk of developing diabetic foot ulcer. Hence, a number of clinical trials are being conducted currently wherein a large number of organizations are actively participating in extended research programs to develop novel therapies for diabetic foot ulcer treatment. Individuals with an increased risk of diabetes are demonstrating alarming hospitalization rates as a result of diabetes foot ulcer infection. This has resulted in a rise in the number of amputations. The occurrence of diabetes and associated risk factors are increasing at an alarming rate, which is expected to fuel revenue growth of the global diabetic foot ulcer therapeutics market during the period of assessment.

Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutics Market
The global Diabetic Foot Ulcer Therapeutics market size is projected to reach US$ 6463.6 million by 2026, from US$ 4057.6 million in 2019, at a CAGR of 6.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Foot Ulcer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Foot Ulcer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Foot Ulcer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Foot Ulcer Therapeutics market.

Global Diabetic Foot Ulcer Therapeutics Scope and Market Size
Diabetic Foot Ulcer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Foot Ulcer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices
Growth Factors

Segment by Application
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
B.Braun Melsungen
Smith & Nephew
Organogenesis
Derma Sciences
Sigvaris
3M
Acelity
Innocoll Holdings
SIGVARIS

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Foot Ulcer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Advance Wound Dressings
1.2.3 Skin Substitutes
1.2.4 Negative Pressure Wound Therapy Devices
1.2.5 Growth Factors
1.3 Market by Application
1.3.1 Global Diabetic Foot Ulcer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Long-Term Care Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diabetic Foot Ulcer Therapeutics Market Perspective (2016-2027)
2.2 Diabetic Foot Ulcer Therapeutics Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Foot Ulcer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Foot Ulcer Therapeutics Industry Dynamic
2.3.1 Diabetic Foot Ulcer Therapeutics Market Trends
2.3.2 Diabetic Foot Ulcer Therapeutics Market Drivers
2.3.3 Diabetic Foot Ulcer Therapeutics Market Challenges
2.3.4 Diabetic Foot Ulcer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Revenue
3.1.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Foot Ulcer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Foot Ulcer Therapeutics Revenue
3.4 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio
3.4.1 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Foot Ulcer Therapeutics Revenue in 2020
3.5 Diabetic Foot Ulcer Therapeutics Key Players Head office and Area Served
3.6 Key Players Diabetic Foot Ulcer Therapeutics Product Solution and Service
3.7 Date of Enter into Diabetic Foot Ulcer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Foot Ulcer Therapeutics Breakdown Data by Type
4.1 Global Diabetic Foot Ulcer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Diabetic Foot Ulcer Therapeutics Breakdown Data by Application
5.1 Global Diabetic Foot Ulcer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
6.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Type
6.2.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
6.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Application
6.3.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
6.4 North America Diabetic Foot Ulcer Therapeutics Market Size by Country
6.4.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
7.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type
7.2.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application
7.3.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country
7.4.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
9.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type
9.2.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application
9.3.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country
9.4.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 B.Braun Melsungen
11.1.1 B.Braun Melsungen Company Details
11.1.2 B.Braun Melsungen Business Overview
11.1.3 B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Introduction
11.1.4 B.Braun Melsungen Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.1.5 B.Braun Melsungen Recent Development
11.2 Smith & Nephew
11.2.1 Smith & Nephew Company Details
11.2.2 Smith & Nephew Business Overview
11.2.3 Smith & Nephew Diabetic Foot Ulcer Therapeutics Introduction
11.2.4 Smith & Nephew Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.2.5 Smith & Nephew Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Diabetic Foot Ulcer Therapeutics Introduction
11.3.4 Organogenesis Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.3.5 Organogenesis Recent Development
11.4 Derma Sciences
11.4.1 Derma Sciences Company Details
11.4.2 Derma Sciences Business Overview
11.4.3 Derma Sciences Diabetic Foot Ulcer Therapeutics Introduction
11.4.4 Derma Sciences Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.4.5 Derma Sciences Recent Development
11.5 Sigvaris
11.5.1 Sigvaris Company Details
11.5.2 Sigvaris Business Overview
11.5.3 Sigvaris Diabetic Foot Ulcer Therapeutics Introduction
11.5.4 Sigvaris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.5.5 Sigvaris Recent Development
11.6 3M
11.6.1 3M Company Details
11.6.2 3M Business Overview
11.6.3 3M Diabetic Foot Ulcer Therapeutics Introduction
11.6.4 3M Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.6.5 3M Recent Development
11.7 Acelity
11.7.1 Acelity Company Details
11.7.2 Acelity Business Overview
11.7.3 Acelity Diabetic Foot Ulcer Therapeutics Introduction
11.7.4 Acelity Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.7.5 Acelity Recent Development
11.8 Innocoll Holdings
11.8.1 Innocoll Holdings Company Details
11.8.2 Innocoll Holdings Business Overview
11.8.3 Innocoll Holdings Diabetic Foot Ulcer Therapeutics Introduction
11.8.4 Innocoll Holdings Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.8.5 Innocoll Holdings Recent Development
11.9 SIGVARIS
11.9.1 SIGVARIS Company Details
11.9.2 SIGVARIS Business Overview
11.9.3 SIGVARIS Diabetic Foot Ulcer Therapeutics Introduction
11.9.4 SIGVARIS Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.9.5 SIGVARIS Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Diabetic Foot Ulcer Therapeutics Introduction
11.10.4 Osiris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.10.5 Osiris Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病性足潰瘍(DFU)治療の世界市場規模・現状・予測2021年-2027年(Global Diabetic Foot Ulcer Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。